美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA210824"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
68001-540-36 68001-540 HUMAN PRESCRIPTION DRUG Bortezomib Bortezomib INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS; SUBCUTANEOUS 20220516 N/A ANDA ANDA210824 BluePoint Laboratories BORTEZOMIB 3.5 mg/1 1 VIAL in 1 CARTON (68001-540-36) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
50742-484-01 50742-484 HUMAN PRESCRIPTION DRUG Bortezomib Bortezomib INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS; SUBCUTANEOUS 20220501 N/A ANDA ANDA210824 Ingenus Pharmaceuticals, LLC BORTEZOMIB 3.5 mg/1 1 VIAL in 1 CARTON (50742-484-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase